According to the “Beijing Yizhuang” official account, recently, the first batch of processing and R&D industrial space projects on the Z21 plot of the Yizhuang Comprehensive Insurance Zone passed the completion inspection. According to reports, the total construction area of the project is about 24,000 square meters, mainly including single buildings such as R&D Center No. 2 and Processing Plant No. 3. It will be used as an R&D transformation area in the Yizhuang Comprehensive Insurance Zone to provide “standardised+customized” plant space and shared services. Up to now, the first-line import and export trade volume of the Yizhuang Comprehensive Insurance Zone has exceeded 4 billion yuan, mainly including biomedical products such as insulin glargine and immune human thymocyte immunoglobulin, as well as high-end manufacturing equipment such as vacuum valves and chemical vapor deposition equipment.

According to the “Beijing Yizhuang” official account, recently, the first batch of processing and R&D industrial space projects on the Z21 plot of the Yizhuang Comprehensive Insurance Zone passed the completion inspection. According to reports, the total construction area of the project is about 24,000 square meters, mainly including single buildings such as R&D Center No. 2 and Processing Plant No. 3. It will be used as an R&D transformation area in the Yizhuang Comprehensive Insurance Zone to provide “standardised+customized” plant space and shared services. Up to now, the first-line import and export trade volume of the Yizhuang Comprehensive Insurance Zone has exceeded 4 billion yuan, mainly including biomedical products such as insulin glargine and immune human thymocyte immunoglobulin, as well as high-end manufacturing equipment such as vacuum valves and chemical vapor deposition equipment.